Isoquinoline potassium channel inhibitors

Details for Australian Patent Application No. 2004276268 (hide)

Owner Merck & Co., Inc.

Inventors Dinsmore, Christopher J.; Liverton, Nigel; Mcintyre, Charles J.; Isaacs, Richard; Claremon, David A.; Trotter, B. Wesley; Nanda, Kausik K.; Beshore, Douglas C.; Kett, Nathan R.

Agent Spruson & Ferguson

Pub. Number AU-B-2004276268

PCT Pub. Number WO2005/030729

Priority 60/505,216 23.09.03 US

Filing date 22 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 29 January 2009

International Classifications

C07D 217/26 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/030729 Priority application(s): WO2005/030729

29 January 2009 Application Accepted

  Published as AU-B-2004276268

28 May 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276276-Inflatable lap belt safety bag

2004276267-Isoquinolinone potassium channel inhibitors